| Invasive validation of a new oscillometric device (Arteriograph) for measuring augmentation index, central blood pressure and aortic pulse wave velocity IG Horvath, A Nemeth, Z Lenkey, N Alessandri, F Tufano, P Kis, ... Journal of hypertension 28 (10), 2068-2075, 2010 | 481 | 2010 |
| A new oscillometric method for assessment of arterial stiffness: comparison with tonometric and piezo-electronic methods J Baulmann, U Schillings, S Rickert, S Uen, R Düsing, M Illyes, A Cziraki, ... Journal of hypertension 26 (3), 523-528, 2008 | 448 | 2008 |
| Reference values of aortic pulse wave velocity in a large healthy population aged between 3 and 18 years EV Hidvégi, M Illyés, B Benczúr, RM Böcskei, L Rátgéber, Z Lenkey, ... Journal of hypertension 30 (12), 2314-2321, 2012 | 133 | 2012 |
| Beneficial effects of a novel ultrapotent poly (ADP-ribose) polymerase inhibitor in murine models of heart failure P Pacher, L Liaudet, JG Mabley, A Cziráki, G Haskó, C Szabó International journal of molecular medicine 17 (2), 369-375, 2006 | 104 | 2006 |
| Suppression of poly (ADP‐ribose) polymerase activation by 3‐aminobenzamide in a rat model of myocardial infarction: long‐term morphological and functional consequences L Liaudet, É Szabó, L Timashpolsky, L Virág, A Cziráki, C Szabó British journal of pharmacology 133 (8), 1424-1430, 2001 | 104 | 2001 |
| Comparison of aortic and carotid arterial stiffness parameters in patients with verified coronary artery disease B Gaszner, Z Lenkey, M Illyés, Z Sárszegi, IG Horváth, B Magyari, ... Clinical cardiology 35 (1), 26-31, 2012 | 62 | 2012 |
| Role of poly (ADP-ribose) polymerase activation in endotoxin-induced cardiac collapse in rodents P Pacher, A Cziráki, JG Mabley, L Liaudet, L Papp, C Szabó Biochemical pharmacology 64 (12), 1785-1791, 2002 | 62 | 2002 |
| INO-1001 a novel poly (ADP-ribose) polymerase (PARP) inhibitor improves cardiac and pulmonary function after crystalloid cardioplegia and extracorporal circulation G Szabó, P Soós, S Mandera, U Heger, C Flechtenmacher, S Bährle, ... Shock 21 (5), 426-432, 2004 | 52 | 2004 |
| L-arginine-nitric oxide-asymmetric dimethylarginine pathway and the coronary circulation: translation of basic science results to clinical practice A Cziráki, Z Lenkey, E Sulyok, I Szokodi, A Koller Frontiers in pharmacology 11, 569914, 2020 | 50 | 2020 |
| cGMP accumulation and gene expression of soluble guanylate cyclase in human vascular tissue A Papapetropoulos, A Cziraki, JW Rubin, CD Stone, JD Catravas Journal of cellular physiology 167 (2), 213-221, 1996 | 48 | 1996 |
| Influence of body height on aortic systolic pressure augmentation and wave reflection in childhood EV Hidvégi, M Illyés, FT Molnár, A Cziráki Journal of human hypertension 29 (8), 495-501, 2015 | 34 | 2015 |
| Physiological regulation of cardiac contractility by endogenous reactive oxygen species A Perjes, AM Kubin, A Konyi, S Szabados, A Cziraki, R Skoumal, ... Acta Physiologica 205 (1), 26-40, 2012 | 34 | 2012 |
| The effect of physical exercise on arterial stiffness parameters in young sportsmen L Rátgéber, ZA Lenkey, Á Németh, E Hidvégi, R Husznai, ZA Verzár, ... Acta cardiologica 70 (1), 59-65, 2015 | 25 | 2015 |
| Human heart mitochondria do not produce physiologically relevant quantities of nitric oxide A Csordás, E Pankotai, JA Snipes, A Cselenyák, Z Sárszegi, A Cziráki, ... Life sciences 80 (7), 633-637, 2007 | 23 | 2007 |
| Elevated levels of Asymmetric Dimethylarginine (ADMA) in the pericardial fluid of cardiac patients correlate with cardiac hypertrophy Z Nemeth, A Cziraki, S Szabados, B Biri, S Keki, A Koller PloS one 10 (8), e0135498, 2015 | 21 | 2015 |
| Comparison of arterial stiffness parameters in patients with coronary artery disease and diabetes mellitus using Arteriograph Z Lenkey, M Illyés, R Böcskei, R Husznai, Z Sárszegi, Z Meiszterics, ... Physiological research 63 (4), 429, 2014 | 19 | 2014 |
| Stent placement in patients with coronary heart disease decreases plasma levels of the endogenous nitric oxide synthase inhibitor ADMA Z Ajtay, F Scalera, A Cziráki, I Horváth, L Papp, E Sulyok, C Szabo, ... International journal of molecular medicine 23 (5), 651-657, 2009 | 19 | 2009 |
| Effects of coronary revascularization with or without cardiopulmonary bypass on plasma levels of asymmetric dimethylarginine A Cziráki, Z Ajtay, Á Németh, Z Lenkey, E Sulyok, S Szabados, N Alotti, ... Coronary artery disease 22 (4), 245-252, 2011 | 18 | 2011 |
| Soluble urokinase-type plasminogen activator receptor and arterial stiffness in patients with COPD RM Böcskei, B Benczúr, G Losonczy, M Illyés, A Cziráki, V Müller, ... Lung 197, 189-197, 2019 | 17 | 2019 |
| Transcutaneous carbon dioxide treatment is capable of reducing peripheral vascular resistance in hypertensive patients B Nemeth, I Kiss, B Ajtay, I Peter, Z Kreska, A Cziraki, IG Horvath, Z Ajtay in vivo 32 (6), 1555-1559, 2018 | 17 | 2018 |
